John Haanen

John Haanen is Professor of Translational Immunotherapy of Cancer at Leiden University. At Netherlands Cancer Institute he has a position as CSO Immunotherapy, one of the major research themes at NKI to increase immunotherapy research, facilitate more translational research programs and start building the NKI Center for Cellular Therapy (solid cancers). His current research spreads over development of cellular therapies for solid tumours, neoadjuvant immunotherapies (renal cell cancer, involvement in GI cancers and head and neck cancers), and biomarker research. His clinical specialty is in melanoma and other skin cancers, kidney cancer and management of immune-related adverse events.